{
    "Trade/Device Name(s)": [
        "Elecsys RBC Folate Hemolyzing Reagent",
        "Roche Elecsys Folate II Immunoassay",
        "Roche Elecsys Folate I Immunoassay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K051292",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981931"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGN"
    ],
    "Summary Letter Date": "June 17, 2005",
    "Summary Letter Received Date": "May 18, 2005",
    "Submission Date": "May 17, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1295"
    ],
    "Regulation Name(s)": [
        "Folic acid test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Folate"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Serum"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys 2010",
        "MODULAR ANALYTICS E170"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence immunoassay",
        "Binding assay"
    ],
    "Methodologies": [
        "Competitive chemiluminescence",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys RBC Folate Hemolyzing Reagent for preparation of hemolysate specimens to quantitatively determine folate in erythrocytes using Roche Elecsys systems.",
    "Indications for Use Summary": "Binding assay for the in vitro quantitative determination of folate in human serum to aid in the diagnosis and treatment of anemias using Elecsys 2010 and MODULAR ANALYTICS E170 immunoassay analyzers.",
    "fda_folder": "Clinical Chemistry"
}